OUR PRODUCTS

MOBILE APPS

GENERAL INFO

SNDX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Syndax Pharmaceuticals (SNDX) Earnings Date & Reports

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

SNDX is expected to report earnings to fall 12.93% to -72 cents per share on November 11

Syndax Pharmaceuticals SNDX Stock Earnings Reports

Q3'25

Est.

$-0.72

Q2'25

Beat

by $0.18

Q1'25

Beat

by $0.26

Q4'24

Missed

by $0.26

Q3'24

Beat

by $0.09

The last earnings report on August 04 showed earnings per share of -82 cents, beating the estimate of -100 cents. With 3.58M shares outstanding, the current market capitalization sits at 1.37B.

View a ticker or compare two or three

Compare

SNDX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For SNDX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SNDX showed earnings on August 04, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of biopharmaceuticals for novel cancer therapies

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

35 Gatehouse Drive

Phone

+1 781 419-1400

Employees

184

Web

https://www.syndax.com